ArticleBone marrow transplantation2026

Upfront alemtuzumab-based MUD HSCT in childhood aplastic anemia: excellent survival and GRFS, but immune challenges persist.

Audrey Françoise Petit et al.PubMed ↗Publisher ↗

No numbers read from the abstract.